Connection

David Cyranoski to Drug Approval

Back to Details
This is a "connection" page, showing publications David Cyranoski has written about Drug Approval.
David Cyranoski
Connection Strength
1.551
Drug Approval
  1. Why emergency COVID-vaccine approvals pose a dilemma for scientists. Nature. 2020 12; 588(7836):18-19.
    View in: PubMed
    Score: 0.437
  2. Arab nations first to approve Chinese COVID vaccine - despite lack of public data. Nature. 2020 12; 588(7839):548.
    View in: PubMed
    Score: 0.437
  3. China cracks down on fake data in drug trials. Nature. 2017 05 11; 545(7654):275.
    View in: PubMed
    Score: 0.341
  4. The UK has approved a COVID vaccine - here's what scientists now want to know. Nature. 2020 12; 588(7837):205-206.
    View in: PubMed
    Score: 0.109
  5. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes. Nature. 2020 08; 584(7819):17-18.
    View in: PubMed
    Score: 0.107
  6. Chinese hospitals set to sell experimental cell therapies. Nature. 2019 05; 569(7755):170-171.
    View in: PubMed
    Score: 0.098
  7. 2017 in news: The science events that shaped the year. Nature. 2017 12 21; 552(7685):304-307.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.